Barriers to highly active antiretroviral therapy adherence in sub-Saharan Africa

Authors: Selin, Amanda; Mills, Edward J; Nachega, Jean B

Source: Future HIV Therapy, Volume 1, Number 3, September 2007 , pp. 331-339(9)

Buy & download fulltext article:

Price: $73.00 plus tax (Refund Policy)

Abstract:

There are important individual, social, economic and structural barriers to seeking and adhering to highly active antiretroviral therapy in sub-Saharan Africa. We sought to qualitatively review these barriers, including limited access to treatment and care, transport or drug costs, pharmacy stock outs, stigmatization of HIV-infected individuals, and, increasingly, alcohol and drug abuse. Rigorous analysis of barriers to treatment and adherence may assist the development of effective interventions to maintain and promote adequate adherence. Overcoming these barriers is critical to reducing the burden of HIV/AIDS in Africa.

Keywords: adherence; Africa; barriers; economic; social; structural

Document Type: Research article

DOI: http://dx.doi.org/10.2217/17469600.1.3.331

Publication date: 2007-09-01

More about this publication?

Future HIV Therapy keeps clinicians and researchers up to date with the significant advances that will enable us to develop new treatments to target the virus and any resistant strains that might develop, and also to improve side effects, adherence and education in therapy, and simplify drug regimens and reduce costs.
Editorial Board
Information for Authors
Submit a Paper
Subscribe to this Title
Information for Advertisers
Terms & Conditions
Information for Librarians
E-Access Trials
ingentaconnect is not responsible for the content or availability of external websites